Skip to main content
Top
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD

Authors: Ester Roos-Engstrand, Jamshid Pourazar, Annelie F Behndig, Anders Blomberg, Anders Bucht

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

A suggested role for T cells in COPD pathogenesis is based on associations between increased lung cytotoxic T lymphocyte (CD8+) numbers and airflow limitation. CD69 is an early T cell activation marker. Natural Killer cell group 2 D (NKG2D) receptors are co-stimulatory molecules induced on CD8+ T cells upon activation. The activating function of NKG2 D is triggered by binding to MHC class 1 chain-related (MIC) molecules A and B, expressed on surface of stressed epithelial cells. The aim of this study was to evaluate the expression of MIC A and B in the bronchial epithelium and NKG2 D and CD69 on BAL lymphocytes in subjects with COPD, compared to smokers with normal lung function and healthy never-smokers.

Methods

Bronchoscopy with airway lavages and endobronchial mucosal biopsy sampling was performed in 35 patients with COPD, 21 healthy never-smokers and 16 smokers with normal lung function. Biopsies were immunohistochemically stained and BAL lymphocyte subsets were determined using flow cytometry.

Results

Epithelial CD3+ lymphocytes in bronchial biopsies were increased in both smokers with normal lung function and in COPD patients, compared to never-smokers. Epithelial CD8+ lymphocyte numbers were higher in the COPD group compared to never-smoking controls. Among gated CD3+cells in BAL, the percentage of CD8+ NKG2D+ cells was enhanced in patients with COPD and smokers with normal lung function, compared to never-smokers. The percentage of CD8+ CD69+ cells and cell surface expression of CD69 were enhanced in patients with COPD and smokers with normal lung function, compared to never-smokers. No changes in the expression of MIC A or MIC B in the airway epithelium could be detected between the groups, whereas significantly decreased soluble MICB was detected in bronchial wash from smokers with normal lung function, compared to never-smokers.

Conclusions

In COPD, we found increased numbers of cytotoxic T cells in both bronchial epithelium and airway lumen. Further, the proportions of CD69- and NKG2D-expressing cytotoxic T cells in BAL fluid were enhanced in both subjects with COPD and smokers with normal lung function and increased expression of CD69 was found on CD8+ cells, indicating the cigarette smoke exposure-induced expansion of activated cytotoxic T cells, which potentially can respond to stressed epithelial cells.
Literature
1.
go back to reference Saetta M: Airway inflammation in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 1999,160(5 Pt 2):S17–20.CrossRefPubMed Saetta M: Airway inflammation in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 1999,160(5 Pt 2):S17–20.CrossRefPubMed
2.
go back to reference Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM: CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 1998,157(3 Pt 1):822–826.CrossRefPubMed Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM: CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 1998,157(3 Pt 1):822–826.CrossRefPubMed
3.
go back to reference Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respiratory care 2001,46(8):798–825.PubMed Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respiratory care 2001,46(8):798–825.PubMed
4.
go back to reference Lams BE, Sousa AR, Rees PJ, Lee TH: Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000,15(3):512–516.CrossRefPubMed Lams BE, Sousa AR, Rees PJ, Lee TH: Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000,15(3):512–516.CrossRefPubMed
5.
go back to reference O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK: Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. American journal of respiratory and critical care medicine 1997,155(3):852–857.CrossRefPubMed O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK: Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. American journal of respiratory and critical care medicine 1997,155(3):852–857.CrossRefPubMed
6.
go back to reference Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, Timens W: Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000,55(1):12–18.CrossRefPubMedPubMedCentral Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, Timens W: Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000,55(1):12–18.CrossRefPubMedPubMedCentral
7.
go back to reference Saetta M, Baraldo S, Turato G, Beghe B, Casoni GL, Bellettato CM, Rea F, Zuin R, Fabbri LM, Papi A: Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. Sarcoidosis Vasc Diffuse Lung Dis 2003,20(1):28–32.PubMed Saetta M, Baraldo S, Turato G, Beghe B, Casoni GL, Bellettato CM, Rea F, Zuin R, Fabbri LM, Papi A: Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. Sarcoidosis Vasc Diffuse Lung Dis 2003,20(1):28–32.PubMed
8.
go back to reference Chrysofakis G, Tzanakis N, Kyriakoy D, Tsoumakidou M, Tsiligianni I, Klimathianaki M, Siafakas NM: Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004,125(1):71–76.CrossRefPubMed Chrysofakis G, Tzanakis N, Kyriakoy D, Tsoumakidou M, Tsiligianni I, Klimathianaki M, Siafakas NM: Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004,125(1):71–76.CrossRefPubMed
9.
go back to reference Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, Hogg JC: Amplification of inflammation in emphysema and its association with latent adenoviral infection. American journal of respiratory and critical care medicine 2001,164(3):469–473.CrossRefPubMed Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, Hogg JC: Amplification of inflammation in emphysema and its association with latent adenoviral infection. American journal of respiratory and critical care medicine 2001,164(3):469–473.CrossRefPubMed
10.
go back to reference Sethi S, Murphy TF: Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clinical microbiology reviews 2001,14(2):336–363.CrossRefPubMedPubMedCentral Sethi S, Murphy TF: Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clinical microbiology reviews 2001,14(2):336–363.CrossRefPubMedPubMedCentral
11.
go back to reference Lofdahl MJ, Roos-Engstrand E, Pourazar J, Bucht A, Dahlen B, Elmberger G, Blomberg A, Skold CM: Increased intraepithelial T-cells in stable COPD. Respiratory medicine 2008,102(12):1812–1818.CrossRefPubMed Lofdahl MJ, Roos-Engstrand E, Pourazar J, Bucht A, Dahlen B, Elmberger G, Blomberg A, Skold CM: Increased intraepithelial T-cells in stable COPD. Respiratory medicine 2008,102(12):1812–1818.CrossRefPubMed
12.
go back to reference Roos-Engstrand E, Ekstrand-Hammarstrom B, Pourazar J, Behndig AF, Bucht A, Blomberg A: Influence of smoking cessation on airway T lymphocyte subsets in COPD. Copd 2009,6(2):112–120.CrossRefPubMed Roos-Engstrand E, Ekstrand-Hammarstrom B, Pourazar J, Behndig AF, Bucht A, Blomberg A: Influence of smoking cessation on airway T lymphocyte subsets in COPD. Copd 2009,6(2):112–120.CrossRefPubMed
13.
go back to reference Ziegler SF, Ramsdell F, Alderson MR: The activation antigen CD69. Stem cells (Dayton, Ohio) 1994,12(5):456–465.CrossRef Ziegler SF, Ramsdell F, Alderson MR: The activation antigen CD69. Stem cells (Dayton, Ohio) 1994,12(5):456–465.CrossRef
14.
go back to reference Gleimer M, Parham P: Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity 2003,19(4):469–477.CrossRefPubMed Gleimer M, Parham P: Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity 2003,19(4):469–477.CrossRefPubMed
15.
go back to reference Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN: Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. American journal of respiratory cell and molecular biology 2007,37(6):748–755.CrossRefPubMed Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN: Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. American journal of respiratory cell and molecular biology 2007,37(6):748–755.CrossRefPubMed
16.
go back to reference Maasho K, Opoku-Anane J, Marusina AI, Coligan JE, Borrego F: NKG2 D is a costimulatory receptor for human naive CD8+ T cells. J Immunol 2005,174(8):4480–4484.CrossRefPubMed Maasho K, Opoku-Anane J, Marusina AI, Coligan JE, Borrego F: NKG2 D is a costimulatory receptor for human naive CD8+ T cells. J Immunol 2005,174(8):4480–4484.CrossRefPubMed
17.
go back to reference Borchers MT, Harris NL, Wesselkamper SC, Vitucci M, Cosman D: NKG2 D ligands are expressed on stressed human airway epithelial cells. American journal of physiology 2006,291(2):L222–231.PubMed Borchers MT, Harris NL, Wesselkamper SC, Vitucci M, Cosman D: NKG2 D ligands are expressed on stressed human airway epithelial cells. American journal of physiology 2006,291(2):L222–231.PubMed
18.
go back to reference Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al.: Antielastin autoimmunity in tobacco smoking-induced emphysema. Nature medicine 2007,13(5):567–569.CrossRefPubMed Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al.: Antielastin autoimmunity in tobacco smoking-induced emphysema. Nature medicine 2007,13(5):567–569.CrossRefPubMed
19.
go back to reference Borchers MT, Wesselkamper SC, Curull V, Ramirez-Sarmiento A, Sanchez-Font A, Garcia-Aymerich J, Coronell C, Lloreta J, Agusti AG, Gea J, et al.: Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. The Journal of clinical investigation 2009,119(3):636–649.CrossRefPubMedPubMedCentral Borchers MT, Wesselkamper SC, Curull V, Ramirez-Sarmiento A, Sanchez-Font A, Garcia-Aymerich J, Coronell C, Lloreta J, Agusti AG, Gea J, et al.: Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. The Journal of clinical investigation 2009,119(3):636–649.CrossRefPubMedPubMedCentral
20.
go back to reference Kraetzel K, Stoelcker B, Eissner G, Multhoff G, Pfeifer M, Holler E, Schulz C: NKG2D-dependent effector function of bronchial epithelium-activated alloreactive T-cells. Eur Respir J 2008,32(3):563–570.CrossRefPubMed Kraetzel K, Stoelcker B, Eissner G, Multhoff G, Pfeifer M, Holler E, Schulz C: NKG2D-dependent effector function of bronchial epithelium-activated alloreactive T-cells. Eur Respir J 2008,32(3):563–570.CrossRefPubMed
21.
go back to reference Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T: Costimulation of CD8alphabeta T cells by NKG2 D via engagement by MIC induced on virus-infected cells. Nature immunology 2001,2(3):255–260.CrossRefPubMed Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T: Costimulation of CD8alphabeta T cells by NKG2 D via engagement by MIC induced on virus-infected cells. Nature immunology 2001,2(3):255–260.CrossRefPubMed
22.
go back to reference American Thoracic Society, Lung function testing:selection of reference values and interpretative strategiesAm Rev Respi Dis 1991, 144:1202–1218. American Thoracic Society, Lung function testing:selection of reference values and interpretative strategiesAm Rev Respi Dis 1991, 144:1202–1218.
23.
go back to reference Britten KM, Howarth PH, Roche WR: Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993,68(5):271–280.CrossRefPubMed Britten KM, Howarth PH, Roche WR: Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993,68(5):271–280.CrossRefPubMed
24.
go back to reference Blomberg A, Krishna MT, Bocchino V, Biscione GL, Shute JK, Kelly FJ, Frew AJ, Holgate ST, Sandstrom T: The inflammatory effects of 2 ppm NO2 on the airways of healthy subjects. Am J Respir Crit Care Med 1997,156(2 Pt 1):418–424.CrossRefPubMed Blomberg A, Krishna MT, Bocchino V, Biscione GL, Shute JK, Kelly FJ, Frew AJ, Holgate ST, Sandstrom T: The inflammatory effects of 2 ppm NO2 on the airways of healthy subjects. Am J Respir Crit Care Med 1997,156(2 Pt 1):418–424.CrossRefPubMed
25.
go back to reference Finkelstein R, Fraser RS, Ghezzo H, Cosio MG: Alveolar inflammation and its relation to emphysema in smokers. American journal of respiratory and critical care medicine 1995,152(5 Pt 1):1666–1672.CrossRefPubMed Finkelstein R, Fraser RS, Ghezzo H, Cosio MG: Alveolar inflammation and its relation to emphysema in smokers. American journal of respiratory and critical care medicine 1995,152(5 Pt 1):1666–1672.CrossRefPubMed
26.
go back to reference Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, et al.: CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 1999,160(2):711–717.CrossRefPubMed Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, et al.: CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 1999,160(2):711–717.CrossRefPubMed
27.
go back to reference Majo J, Ghezzo H, Cosio MG: Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001,17(5):946–953.CrossRefPubMed Majo J, Ghezzo H, Cosio MG: Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001,17(5):946–953.CrossRefPubMed
28.
go back to reference Morissette MC, Parent J, Milot J: Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema. Respiratory research 2007, 8:62.CrossRefPubMedPubMedCentral Morissette MC, Parent J, Milot J: Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema. Respiratory research 2007, 8:62.CrossRefPubMedPubMedCentral
30.
go back to reference Leckie MJ, Jenkins GR, Khan J, Smith SJ, Walker C, Barnes PJ, Hansel TT: Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax 2003,58(1):23–29.CrossRefPubMedPubMedCentral Leckie MJ, Jenkins GR, Khan J, Smith SJ, Walker C, Barnes PJ, Hansel TT: Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax 2003,58(1):23–29.CrossRefPubMedPubMedCentral
31.
go back to reference Sancho D, Gomez M, Sanchez-Madrid F: CD69 is an immunoregulatory molecule induced following activation. Trends in immunology 2005,26(3):136–140.CrossRefPubMed Sancho D, Gomez M, Sanchez-Madrid F: CD69 is an immunoregulatory molecule induced following activation. Trends in immunology 2005,26(3):136–140.CrossRefPubMed
32.
go back to reference Vivier E, Tomasello E, Paul P: Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Current opinion in immunology 2002,14(3):306–311.CrossRefPubMed Vivier E, Tomasello E, Paul P: Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Current opinion in immunology 2002,14(3):306–311.CrossRefPubMed
33.
go back to reference Raulet DH: Roles of the NKG2 D immunoreceptor and its ligands. Nature reviews 2003,3(10):781–790.PubMed Raulet DH: Roles of the NKG2 D immunoreceptor and its ligands. Nature reviews 2003,3(10):781–790.PubMed
Metadata
Title
Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD
Authors
Ester Roos-Engstrand
Jamshid Pourazar
Annelie F Behndig
Anders Blomberg
Anders Bucht
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-128

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine